Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy
NCT00428935
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Duchenne Muscular Dystrophy
Interventions
BIOLOGICAL:
rAAV2.5-CMV-minidystrophin (d3990)
Sponsor
Nationwide Children's Hospital
Collaborators
[object Object]